BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 11349186)

  • 1. Prognostic factors of patients with yolk sac tumors of the ovary.
    Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
    Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
    Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
    Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
    Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients.
    Li J; Yang W; Wu X
    Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors of patients with ovarian yolk sac tumors: a study in Chinese patients.
    Tong X; You Q; Li L; Cai L; Wang C; Zheng J
    Onkologie; 2008 Dec; 31(12):679-84. PubMed ID: 19060506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endodermal sinus tumor of the ovary: the Hacettepe University experience.
    Ayhan A; Taskiran C; Bozdag G; Altinbas S; Altinbas A; Yuce K
    Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):230-4. PubMed ID: 16026921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ovarian germ cell tumors: a single-institution experience.
    Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
    Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD; Zhang Q; Zhang Y
    Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of malignant germ cell tumors of the ovary: a clinical analysis of 233 cases].
    Zhang R; Hong W; Liu L
    Zhonghua Zhong Liu Za Zhi; 1998 Mar; 20(2):155-7. PubMed ID: 10920972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
    Low JJ; Perrin LC; Crandon AJ; Hacker NF
    Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases.
    Barakat RR; Rubin SC; Wong G; Saigo PE; Markman M; Hoskins WJ
    Obstet Gynecol; 1992 Oct; 80(4):660-4. PubMed ID: 1328975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case report.
    McBee WC; Brainard J; Sawady J; Rose PG
    Gynecol Oncol; 2007 Apr; 105(1):244-7. PubMed ID: 17316775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive staging allows for excellent outcome in patients with localized malignant germ cell tumor of the ovary.
    Palenzuela G; Martin E; Meunier A; Beuzeboc P; Laurence V; Orbach D; Frappaz D
    Ann Surg; 2008 Nov; 248(5):836-41. PubMed ID: 18948812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comprehensive staging surgery in treatment of malignant ovarian germ cell tumor].
    Jin Y; Pan LY; Huang HF; Shen K; Wu M; Yang JX; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Dec; 40(12):826-30. PubMed ID: 16412329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case report of a 6-year-old boy with intracranial yolk sac tumor treated by VAB-6 regimen].
    Wada H; Kubo M; Wada T; Ueno Y; Horita S; Ohki T; Munemoto S; Kuroda E; Taguchi H; Muramatsu N
    No Shinkei Geka; 1995 Jan; 23(1):65-8. PubMed ID: 7531296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.